Back to Search Start Over

1470P Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence.

Authors :
Heumann, T.R.
Baretti, M.
Sugar, E.
Durhman, J.
Liden, S.
Miles, T.
Lopez-Vidal, T.Y.
Leatherman, J.
Sharma, A.
Ahuja, N.
Weekes, C.D.
O'Dwyer, P.J.
Monga, D.K.
Reiss Binder, K.A.
Azad, N.
Source :
Annals of Oncology. 2021 Supplement 5, Vol. 32, pS1087-S1088. 2p.
Publication Year :
2021

Subjects

Subjects :
*AZACITIDINE
*ADENOCARCINOMA
*PATIENTS

Details

Language :
English
ISSN :
09237534
Volume :
32
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152689145
Full Text :
https://doi.org/10.1016/j.annonc.2021.08.797
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details